作为冠状动脉疾病的新型炎症生物标志物,TRAF3IP2:开发和验证多式预测模型
Peibing Ge1, Tianyi Ni1, Mengjie Liu1
1Department of Cardiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, China.
TRAF3IP2可能作为冠状动脉疾病 (CAD) 的新生物标志物. 结合性别,糖尿病史,血症和TRAF3IP2的预测性名录显示了对CAD患者临床风险评估的潜力.
科学领域:
- 心血管医学 心血管医学
- 生物标志物发现发现
- 炎症研究 炎症研究
背景情况:
- 冠状动脉疾病 (CAD) 是全球发病率和死亡率的主要原因之一.
- 炎症是动脉样硬化的主要驱动因素,但缺乏可操作的生物标志物.
- 在CAD病原和预测中,TRAF3IP2的作用需要进行系统的研究.
研究的目的:
- 研究TRAF3IP2在冠状动脉疾病的作用.
- 开发和验证一个用于预测CAD风险的名ogram模型.
主要方法:
- 分析了基因表达特征 (GSE12288),以确定CAD中的关键基因和途径.
- 使用LASSO和多变量逻辑回归来确定临床队列 (n=280) 中的风险因素.
- 使用校准曲线和决策曲线分析 (DCA) 构建和评估了一个名图.
主要成果:
- 与对照组相比,CAD患者的TRAF3IP2表达显著更高.
- TRAF3IP2与动脉样硬化中心的炎症反应有关.
- 确定了动脉样硬化的独立危险因素是性别,糖尿病史,血症和TRAF3IP2表达.
结论:
- TRAF3IP2成为冠状动脉疾病的潜在预测生物标志物.
- 综合性别,糖尿病史,血症和TRAF3IP2的nomogram显示了临床CAD风险预测的前景.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
